Advertisement
ResearchIn-Press PreviewGeneticsNeuroscience
Open Access | 10.1172/JCI183434
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Allende, M. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by
Kono, M.
in:
PubMed
|
Google Scholar
|
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Lee, Y. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Olmsted, S. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Huso, V. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Bakir, J. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Pratto, F. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Li, C. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Byrnes, C. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Tuymetova, G. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by Zhu, H. in: PubMed | Google Scholar
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by
Tifft, C.
in:
PubMed
|
Google Scholar
|
1Genetics and Biochemistry Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, United States of America
2Medical Genetics Branch, National Human Genome Research Institute, Bethesda, United States of America
Find articles by
Proia, R.
in:
PubMed
|
Google Scholar
|
Published June 17, 2025 - More info
Late-onset Tay-Sachs (LOTS) disease is a lysosomal storage disorder most commonly caused by a point mutation (c.805G>A) in the HEXA gene encoding the α-subunit of the lysosomal enzyme β-hexosaminidase A. LOTS manifests as a range of gradually worsening neurological symptoms beginning in young adulthood. Here, we explored the efficacy of an adenine base editor (ABE) programmed with a small guide RNA (sgRNA) to correct the HEXA c.805G>A mutation. Base editing in LOTS patient fibroblasts successfully converted the pathogenic HEXA c.805A to G and partially restored β-hexosaminidase activity, with minimal genome-wide off-target editing. We generated a LOTS mouse model in which the mice exhibited decreased β-hexosaminidase activity, accumulation of GM2 ganglioside in the brain, progressive neurological manifestations, and reduced lifespan. Treatment of LOTS mice with the neurotropic virus AAV-PHP.eB carrying the ABE and an sgRNA targeting the LOTS point mutation partially corrected the c.805G>A mutation in the CNS, significantly increased brain β-hexosaminidase activity, and substantially reduced GM2 ganglioside accumulation in the brain. Moreover, the therapy delayed symptom onset and significantly extended median lifespan. These findings highlight the potential of base editing as an effective treatment for LOTS and its broader applicability to other lysosomal storage disorders.